|1||NCT00486668||Unknown †||A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer||
||Other / Industry||
||529||Female||18 Years and older (Adult, Older Adult)||NCT00486668||NSABP B-41||July 2007||June 2012||March 2017||June 15, 2007||June 6, 2016||
|2||NCT03272477||Recruiting||Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients||
||Industry / Other||
||259||Female||18 Years and older (Adult, Older Adult)||NCT03272477||PH002-TP-II||TP-II||August 22, 2017||March 15, 2020||November 15, 2024||September 5, 2017||September 20, 2017||
† Study has passed its completion date and status has not been verified in more than two years.